Publications

Science in the time of COVID-19: Reflections on the UK Events Research Programme.

Marteau, TM; Parker, MJ; EDMUNDS, WJ;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-32366-1.

cmmid/SA2UK: CEA submission.

PEARSON, CA B; RUSSELL, TW; KUCHARSKI, AJ;

2022

, Zenodo (2022).

Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in England.

NAYLOR, NR; Evans, S; Pouwels, KB; Troughton, R; Lamagni, T; Muller-Pebody, B; KNIGHT, GM; Atun, R; Robotham, JV;

2022

Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.803943.

Respondent-Driven Sampling and Total Population Data from a Rural Ugandan Cohort, 2010: Special Licence Access.

MRC/UVRI,; WHITE, R;

2022

, UK Data Service (Essex, United Kingdom) (2022).

"We've all got the virus inside us now": Disaggregating public health relations and responsibilities for health protection in pandemic London.

Kasstan, B; MOUNIER-JACK, S; GASKELL, KM; EGGO, RM; MARKS, M; CHANTLER, T;

2022

Social Science and Medicine, (2022).309, 10.1016/j.socscimed.2022.115237.

hamishgibbs/facebook_population_2020_2021.

Gibbs, H; Waterlow, NR; Cheshire, J; Danon, L; LIU, Y; Grundy, C; Kucharski, AJ; EGGO, RM;

2022

, Github (2022).

Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.

Burger, E; Baussano, I; Kim, JJ; Laprise, J-F; Berkhof, J; Schiller, JT; Canfell, K; PREM, K; Brisson, M; JIT, M; Barnabas, RV;

2022

Vaccine, (2022).41 16 10.1016/j.vaccine.2022.07.022.

Effect of pneumococcal conjugate vaccine on prevalence of otitis media with effusion among children in Vietnam.

Toizumi, M; Satoh, C; QUILTY, BJ; Nguyen, HA T; Madaniyazi, L; Le, LT; Ng, CF S; Hara, M; Iwasaki, C; Takegata, M; Kitamura, N; Nation, ML; Satzke, C; Kumai, Y; Do, HT; Bui, MX; Mulholland, K; FLASCHE, S; Dang, DA; Kaneko, K; Yoshida, L-M;

2022

Vaccine, (2022).40 36 10.1016/j.vaccine.2022.07.047.

Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England.

The OpenSAFELY Collaborative,; Nab, L; PARKER, EP K; Andrews, C; Hulme, W; Fisher, L; Morley, J; Mehrkar, A; MacKenna, B; Inglesby, P; Morton, C; Bacon, SC J; Hickman, G; Evans, D; Ward, T; Smith, R; Davey, S; Dillingham, I; Maude, S; Butler-Cole, BF C; O'Dwyer, T; Stables, C; Bridges, L; Bates, C; Cockburn, J; ... Walker, A.

2022

medRxiv (2022). 10.1101/2022.07.30.22278161.

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.

Orangi, S; Ojal, J; Brand, SP; Orlendo, C; Kairu, A; Aziza, R; Ogero, M; AGWEYU, A; Warimwe, GM; Uyoga, S; Otieno, E; Ochola-Oyier, LI; Agoti, CN; Kasera, K; Amoth, P; Mwangangi, M; Aman, R; Ng'ang'a, W; ADETIFA, IM; SCOTT, JA G; Bejon, P; Keeling, MJ; FLASCHE, S; Nokes, DJ; Barasa, E;

2022

BMJ Global Health, (2022).7 8 10.1136/bmjgh-2022-009430.